UA83680U - Способ комплексной реабилитации больных нейродермитом - Google Patents
Способ комплексной реабилитации больных нейродермитомInfo
- Publication number
- UA83680U UA83680U UAU201303460U UAU201303460U UA83680U UA 83680 U UA83680 U UA 83680U UA U201303460 U UAU201303460 U UA U201303460U UA U201303460 U UAU201303460 U UA U201303460U UA 83680 U UA83680 U UA 83680U
- Authority
- UA
- Ukraine
- Prior art keywords
- neurodermatitis
- patients
- complex rehabilitation
- complex
- rehabilitation
- Prior art date
Links
- 201000009053 Neurodermatitis Diseases 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 abstract 2
- -1 adaptogens Substances 0.000 abstract 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 abstract 2
- KWTQSFXGGICVPE-WCCKRBBISA-N Arginine hydrochloride Chemical compound Cl.OC(=O)[C@@H](N)CCCN=C(N)N KWTQSFXGGICVPE-WCCKRBBISA-N 0.000 abstract 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 abstract 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 abstract 1
- 229940125715 antihistaminic agent Drugs 0.000 abstract 1
- 239000000739 antihistaminic agent Substances 0.000 abstract 1
- 239000003963 antioxidant agent Substances 0.000 abstract 1
- 229940009098 aspartate Drugs 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 229960000304 folic acid Drugs 0.000 abstract 1
- 235000019152 folic acid Nutrition 0.000 abstract 1
- 239000011724 folic acid Substances 0.000 abstract 1
- 229910052500 inorganic mineral Inorganic materials 0.000 abstract 1
- 238000002647 laser therapy Methods 0.000 abstract 1
- 239000011707 mineral Substances 0.000 abstract 1
- 229940125723 sedative agent Drugs 0.000 abstract 1
- 239000000932 sedative agent Substances 0.000 abstract 1
- 239000011780 sodium chloride Substances 0.000 abstract 1
- 239000000021 stimulant Substances 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Способ комплексного лечения больных нейродермитом предусматривает введение антигистаминных, антиоксидантов, биостимуляторов, адаптогенов, седативных лечебных средств. При этом дополнительно вводят препарат тивортин аспартат, декамевит, фолиевую кислоту, минеральную хлоридную натриевую воду «Бронничанка» и лазеротерапию.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UAU201303460U UA83680U (ru) | 2013-03-21 | 2013-03-21 | Способ комплексной реабилитации больных нейродермитом |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UAU201303460U UA83680U (ru) | 2013-03-21 | 2013-03-21 | Способ комплексной реабилитации больных нейродермитом |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA83680U true UA83680U (ru) | 2013-09-25 |
Family
ID=52279020
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAU201303460U UA83680U (ru) | 2013-03-21 | 2013-03-21 | Способ комплексной реабилитации больных нейродермитом |
Country Status (1)
| Country | Link |
|---|---|
| UA (1) | UA83680U (ru) |
-
2013
- 2013-03-21 UA UAU201303460U patent/UA83680U/ru unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12017502154A1 (en) | Methods for conditioning patients for t cell therapy | |
| CY1124135T1 (el) | Δοσολογικα σχηματα για την αγωγη της νοσου ρομρε | |
| MX2017014338A (es) | Seleccion dirigida de pacientes para el tratamiento con derivados de cortistatina. | |
| PH12014502738A1 (en) | High-xten fusion protein and its use in the treatment of growth hormone deficiency | |
| MX2021000071A (es) | Uso de pridopidina para mejorar la funcion cognitiva y para tratamiento de enfermedad de alzheimer. | |
| IN2014DN11099A (ru) | ||
| BR112015026006A2 (pt) | métodos para o tratamento de câncer com o uso de terapia de combinação com inibidor de cinase tor | |
| MX2016000173A (es) | Sistemas y metodos para seguimiento y presentacion de datos de terapia para acufenos. | |
| MX2013000319A (es) | Tratamiento de transtornos cognitivos. | |
| MX2015012322A (es) | Uso de levocetirizina y montelukast en el tratamiento de trastornos autoinmunes. | |
| MX2015016527A (es) | Polimeros enlazados al proton para administracion oral. | |
| IN2015DN03219A (ru) | ||
| AR089862A1 (es) | USO DE LAQUINIMOD PARA EL TRATAMIENTO DE PACIENTES CON ENFERMEDAD DE CROHN EN QUIENES FRACASO UNA TERAPIA ANTI-FACTOR DE NECROSIS TUMORAL a (ANTI-TNFa) DE PRIMERA LINEA | |
| MX2015011905A (es) | Uso de levocetirizina y montelukast en el tratamiento de la vasculitis. | |
| MX2021004558A (es) | Polimeros de union a protones para administracion oral. | |
| MX2018010223A (es) | Terapia combinada para tratamiento de cancer de ovario. | |
| PH12015502616A1 (en) | Pharmaceutical combination comprising metformin and dihydroquercetin and its use for the treatment of cancer | |
| ZA201708686B (en) | Nanoparticles for use as a therapeutic vaccine | |
| PH12016502233A1 (en) | (s)-pirlindole or its pharmaceutically acceptable salts for use in medicine | |
| PH12016502236A1 (en) | (r)-pirlindole and its pharmaceutically acceptable salts for use in medicine | |
| MX349767B (es) | Cloruro de dietil-[6-(4-hidroxicarbamoil-fenil-carbamoiloxi-metil) -naftalen-2-il-metil]-amonio para su uso en el tratamiento de distrofia muscular. | |
| UA83680U (ru) | Способ комплексной реабилитации больных нейродермитом | |
| MX2017013668A (es) | Terapia de combinacion de agente anti-fuctactico y agente anti-cancer y composiciones para el tratamiento de cancer. | |
| TN2014000418A1 (en) | Methods for treating cancer using pi3k inhibitor and mek inhibitor | |
| UA112357C2 (uk) | Спосіб індивідуальної цільової терапії дефіциту вітаміну d у пацієнтів із захворюваннями кістково-м'язової системи |